Literature DB >> 21131235

Analysis of mutations and recombination activity in RAG-deficient patients.

Erika Asai1, Taizo Wada, Yasuhisa Sakakibara, Akiko Toga, Tomoko Toma, Takashi Shimizu, Sheela Nampoothiri, Kohsuke Imai, Shigeaki Nonoyama, Tomohiro Morio, Hideki Muramatsu, Yoshiro Kamachi, Osamu Ohara, Akihiro Yachie.   

Abstract

Mutations in the recombination activating genes (RAG1 or RAG2) can lead to a variety of immunodeficiencies. Herein, we report 5 cases of RAG deficiency from 5 families: 3 of Omenn syndrome, 1 of severe combined immunodeficiency, and 1 of combined immunodeficiency with oligoclonal TCRγδ(+) T cells, autoimmunity and cytomegalovirus infection. The genetic defects were heterogeneous and included 6 novel RAG mutations. All missense mutations except for Met443Ile in RAG2 were located in active core regions of RAG1 or RAG2. V(D)J recombination activity of each mutant was variable, ranging from half of the wild type activity to none, however, a significant decrease in average recombination activity was demonstrated in each patient. The reduced recombination activity of Met443Ile in RAG2 may suggest a crucial role of the non-core region of RAG2 in V(D)J recombination. These findings suggest that functional evaluation together with molecular analysis contributes to our broader understanding of RAG deficiency.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131235     DOI: 10.1016/j.clim.2010.11.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.

Authors:  Hassan Abolhassani; Ning Wang; Asghar Aghamohammadi; Nima Rezaei; Yu Nee Lee; Francesco Frugoni; Luigi D Notarangelo; Qiang Pan-Hammarström; Lennart Hammarström
Journal:  J Allergy Clin Immunol       Date:  2014-07-02       Impact factor: 10.793

2.  Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection.

Authors:  Cullen M Dutmer; Edwin J Asturias; Christiana Smith; Megan K Dishop; D Scott Schmid; William J Bellini; Irit Tirosh; Yu Nee Lee; Luigi D Notarangelo; Erwin W Gelfand
Journal:  J Clin Immunol       Date:  2015-10-29       Impact factor: 8.317

3.  RAG1 deficiency may present clinically as selective IgA deficiency.

Authors:  Tamaki Kato; Elena Crestani; Chikako Kamae; Kenichi Honma; Tomoko Yokosuka; Takeshi Ikegawa; Naonori Nishida; Hirokazu Kanegane; Taizo Wada; Akihiro Yachie; Osamu Ohara; Tomohiro Morio; Luigi D Notarangelo; Kohsuke Imai; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2015-03-06       Impact factor: 8.317

4.  Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.

Authors:  Irit Tirosh; Yasuhiro Yamazaki; Francesco Frugoni; Francesca A Ververs; Eric J Allenspach; Yu Zhang; Siobhan Burns; Waleed Al-Herz; Lenora Noroski; Jolan E Walter; Andrew R Gennery; Mirjam van der Burg; Luigi D Notarangelo; Yu Nee Lee
Journal:  J Allergy Clin Immunol       Date:  2018-06-18       Impact factor: 10.793

5.  Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease.

Authors:  Taizo Wada; Masahiro Muraoka; Tomoko Toma; Tsuyoshi Imai; Tomonari Shigemura; Kazunaga Agematsu; Kohei Haraguchi; Hiroyuki Moriuchi; Tsutomu Oh-Ishi; Toshiyuki Kitoh; Osamu Ohara; Tomohiro Morio; Akihiro Yachie
Journal:  J Clin Immunol       Date:  2013-01-10       Impact factor: 8.317

6.  Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.

Authors:  S S Meshaal; R E El Hawary; D S Abd Elaziz; A Eldash; R Alkady; S Lotfy; A A Mauracher; L Opitz; J Pachlopnik Schmid; M van der Burg; J Chou; N M Galal; J A Boutros; R Geha; A M Elmarsafy
Journal:  Clin Exp Immunol       Date:  2018-11-04       Impact factor: 4.330

7.  Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.

Authors:  Necil Kutukculer; Nesrin Gulez; Neslihan Edeer Karaca; Guzide Aksu; Afig Berdeli
Journal:  Ital J Pediatr       Date:  2012-03-16       Impact factor: 2.638

8.  Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in RAG1 associated with B- T- NK+ severe combined immunodeficiency.

Authors:  Geeta Madathil Govindaraj; Shamsudheen Karuthedath Vellarikkal; Rijith Jayarajan; Rowmika Ravi; Ankit Verma; Krishnan Chakkiyar; Machinari Puthenpurayil Jayakrishnan; Riyaz Arakkal; Revathi Raj; Rajeevan Kunnaruvath; Sridhar Sivasubbu; Vinod Scaria
Journal:  F1000Res       Date:  2016-10-18

9.  A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.

Authors:  Yu Nee Lee; Francesco Frugoni; Kerry Dobbs; Jolan E Walter; Silvia Giliani; Andrew R Gennery; Waleed Al-Herz; Elie Haddad; Francoise LeDeist; Jack H Bleesing; Lauren A Henderson; Sung-Yun Pai; Robert P Nelson; Dalia H El-Ghoneimy; Reem A El-Feky; Shereen M Reda; Elham Hossny; Pere Soler-Palacin; Ramsay L Fuleihan; Niraj C Patel; Michel J Massaad; Raif S Geha; Jennifer M Puck; Paolo Palma; Caterina Cancrini; Karin Chen; Mauno Vihinen; Frederick W Alt; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.